Patient-specific tissue engineered vascular graft utilizing electrospinning
US-2018245243-A1 · Aug 30, 2018 · US
US11071617B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11071617-B2 |
| Application number | US-202017063924-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 6, 2020 |
| Priority date | Jun 17, 2010 |
| Publication date | Jul 27, 2021 |
| Grant date | Jul 27, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A multi-laminar electrospun nanofiber scaffold for use in repairing a defect in a tissue substrate is provided. The scaffold includes a first layer formed by a first plurality of electrospun polymeric fibers, and a second layer formed by a second plurality of electrospun polymeric fibers. The second layer is combined with the first layer. A first portion of the scaffold includes a higher density of fibers than a second portion of the scaffold, and the first portion has a higher tensile strength than the second portion. The scaffold is configured to degrade via hydrolysis after at least one of a predetermined time or an environmental condition. The scaffold is configured to be applied to the tissue substrate containing the defect, and is sufficiently flexible to facilitate application of the scaffold to uneven surfaces of the tissue substrate, and to enable movement of the scaffold by the tissue substrate.
Opening claim text (preview).
What is claimed is: 1. A biomedical patch device for tissue repair, the biomedical patch device comprising: a first polymeric scaffold comprising a first structure of fibers having electrospun nanofibers, the first structure of fibers comprising randomly oriented fiber sections, the first structure of fibers configured to promote cell growth for a first period of time upon application of the biomedical patch to a tissue, wherein the first period of time is less than three months; and a second polymeric scaffold comprising a second structure of fibers having electrospun nanofibers, the second structure of fibers comprising a plurality of radially aligned fiber sections and a plurality of randomly oriented fiber sections, wherein one or more of the plurality of radially aliened fiber sections transition into one or more of the plurality of randomly oriented fiber sections of the second structure of fibers, wherein one or more of the plurality of radially aliened fiber sections is overlaid on one or more of the plurality of randomly oriented fiber sections of the second structure of fibers, the second structure of fibers configured to provide structural reinforcement to the first polymeric scaffold for a second period of time upon application of the biomedical patch to the tissue, wherein the second period of time is less than three months; the first structure of fibers and the second structure of fibers generated by depositing via electrospinning a first polymer composition and a second polymer composition, the first polymer composition being different from the second polymer composition; the biomedical patch device further comprising a surface configured to contact tissue upon application of the biomedical patch, the surface, the first polymeric scaffold, and the second polymeric scaffold of the biomedical patch device sufficiently pliable to facilitate application of the biomedical patch device to uneven surfaces of the tissue, the surface, the first polymeric scaffold, and the second polymeric scaffold of the biomedical patch device sufficiently pliable to enable movement of the biomedical patch device with the tissue, and the surface, the first polymeric scaffold, and the second polymeric scaffold of the biomedical patch device comprising sufficient durability to maintain stability of the biomedical patch for a storage period prior to application of the biomedical patch device to the tissue. 2. The biomedical patch of claim 1 , wherein a first portion of the biomedical patch of a particular size comprises a higher number of fibers than a second portion of the biomedical patch of the particular size. 3. The biomedical patch of claim 2 , wherein the surface comprises a surface pattern formed by positioning a mask between a collector and a spinneret, wherein the mask is configured to prevent depositing at least some of the first structure of fibers or the second structure of fibers on the collector. 4. The biomedical patch of claim 2 , wherein the surface comprises a surface pattern formed by depositing the first structure of fibers and the second structure of fibers directly on a collector without a mask. 5. The biomedical patch of claim 4 , wherein the surface pattern comprises a plurality of organized features. 6. The biomedical patch of claim 1 , wherein at least a portion of the first structure of fibers and at least a portion of the second structure of fibers are deposited simultaneously. 7. The biomedical patch of claim 1 , wherein the surface comprises a plurality of structural features configured to align cells. 8. The biomedical patch of claim 1 , wherein the first structure of fibers and the second structure of fibers comprise one or more randomly oriented fibers. 9. The biomedical patch of claim 1 , wherein the first structure of fibers and the second structure of fibers comprise one or more radially aligned fibers. 10. The biomedical patch of claim 1 , wherein the first structure of fibers and the second structure of fibers comprise one or more uniaxially aligned fibers. 11. A biomedical wound matrix for facilitating wound healing, the biomedical wound matrix comprising: a first polymeric scaffold comprising a first structure of fibers having electrospun nanofibers, the first structure of fibers comprising a plurality of randomly oriented portions of fibers, the first structure of fibers configured to promote cell growth upon application of the biomedical wound matrix to a tissue; and a second polymeric scaffold comprising a second structure of fibers having electrospun nanofibers, the second structure of fibers comprising a plurality of radially aligned portions of fibers and a plurality of non-radially aligned portions of fibers, wherein one or more of the plurality of radially aliened portions of fibers transition into one or more of the plurality of non-radially aliened portions of fibers of the second structure of fibers, wherein one or more of the plurality of radially aligned portions of fibers is overlaid on one or more of the plurality of non-radially aliened portions of fibers of the second structure of fibers, the second structure of fibers configured to provide structural reinforcement to the first polymeric scaffold; the first structure of fibers and the second structure of fibers generated by depositing via electrospinning a first polymer composition and a second polymer composition, the first polymer composition being different from the second polymer composition; the biomedical wound matrix further comprising a surface configured to contact tissue upon application of the biomedical wound matrix, the surface, the first polymeric scaffold, and the second polymeric scaffold of the biomedical wound matrix sufficiently pliable to facilitate application of the biomedical wound matrix to uneven surfaces of the tissue, the surface, the first polymeric scaffold, and the second polymeric scaffold of the biomedical wound matrix sufficiently pliable to enable movement of the biomedical wound matrix with the tissue, and wherein the first structure of fibers and the second structure of fibers are configured to degrade after application to the tissue. 12. The biomedical wound matrix of claim 11 , wherein a first portion of the biomedical wound matrix of a particular size comprises a higher number of fibers than a second portion of the biomedical wound matrix of the particular size. 13. The biomedical wound matrix of claim 11 , wherein the first polymeric scaffold comprises a first topographical cue and the second polymeric scaffold comprises a second topographical cue. 14. The biomedical wound matrix of claim 13 , wherein one or more of the first topographical cue or the second topographical cue are randomly oriented to resemble an extracellular matrix. 15. The biomedical wound matrix of claim 11 , wherein the surface comprises a surface pattern comprising a plurality of organized features. 16. The biomedical wound matrix of claim 11 , wherein at least a portion of the first structure of fibers and at least a portion of the second structure of fibers are deposited simultaneously. 17. The biomedical wound matrix of claim 11 , wherein the surface comprises a plurality of structural features configured to facilitate cell growth. 18. The biomedical wound matrix of claim 11 , wherein the first structure of fibers and the second structure of fibers comprise one or more randomly oriented fibers. 19. The biomedical wound matrix of claim 11 , wherein the first structure of fibers and the second structure of fibers comprise
by electro-spinning {(electro-spinning methods and apparatus D01D5/0007)} · CPC title
the fibres being orientated, e.g. in parallel {(anisotropic fleeces)} · CPC title
Formation of filaments, threads, or the like · CPC title
Bandages or dressings (radioactive dressings {A61N5/1029}); Absorbent pads · CPC title
Implantable repair or support meshes, e.g. hernia meshes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.